We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$452M
AUM Growth
+$130M
Cap. Flow
-$18.5M
Cap. Flow %
-4.08%
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97

Top Buys

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3.03M
2
OSPN icon
OneSpan
OSPN
+$2.96M
3
ATEX icon
Anterix
ATEX
+$2.79M
4
CALX icon
Calix
CALX
+$2.73M
5
GNMK
GenMark Diagnostics, Inc
GNMK
+$2.72M

Top Sells

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$3.54M
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$3.44M
3
TDOC icon
Teladoc Health
TDOC
+$3.2M
4
KRYS icon
Krystal Biotech
KRYS
+$3M
5
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.95M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 21.89%
3 Consumer Discretionary 16.2%
4 Industrials 10.05%
5 Consumer Staples 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
26
AtriCure
ATRC
$1.97B
$3.01M 0.66%
66,915
-18,801
-22% -$819K
CSTL icon
27
Castle Biosciences
CSTL
$928M
$2.96M 0.65%
78,601
-11,562
-13% -$395K
CYTK icon
28
Cytokinetics
CYTK
$10.4B
$2.95M 0.65%
+125,178
New +$2.35M
FRPT icon
29
Freshpet
FRPT
$2.93B
$2.92M 0.65%
34,961
+630
+2% +$47.4K
OCUL icon
30
Ocular Therapeutix
OCUL
$1.84B
$2.88M 0.64%
346,075
– –
AAWW
31
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$2.84M 0.63%
+65,930
New +$2.31M
CRNC icon
32
Cerence
CRNC
$403M
$2.83M 0.63%
69,416
-15,740
-18% -$452K
TREX icon
33
Trex
TREX
$4.66B
$2.81M 0.62%
+43,288
New +$2.31M
CYBE
34
DELISTED
Cyberoptics Corp
CYBE
$2.79M 0.62%
86,624
+38,234
+79% +$1.07M
AKBA icon
35
Akebia Therapeutics
AKBA
$351M
$2.74M 0.61%
+201,521
New +$2.08M
TTCF
36
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$2.72M 0.6%
+165,135
New +$2.03M
ADVM
37
DELISTED
Adverum Biotechnologies
ADVM
$2.71M 0.6%
12,980
+2,277
+21% +$403K
ECOM
38
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$2.71M 0.6%
+171,107
New +$1.98M
CHGG icon
39
Chegg
CHGG
$114M
$2.69M 0.59%
+39,964
New +$2.14M
BCRX icon
40
BioCryst Pharmaceuticals
BCRX
$2.24B
$2.69M 0.59%
+563,961
New +$2.25M
KALA icon
41
KALA BIO
KALA
$14.6M
$2.66M 0.59%
101
+20
+25% +$567K
LPTH icon
42
Lightpath Technologies
LPTH
$702M
$2.65M 0.59%
+794,567
New +$1.81M
RDFN
43
DELISTED
Redfin
RDFN
$2.64M 0.58%
+62,948
New +$1.66M
KRTX
44
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.62M 0.58%
23,463
-17,053
-42% -$1.48M
AWH
45
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$2.61M 0.58%
+45,313
New +$3.03M
INSP icon
46
Inspire Medical Systems
INSP
$1.5B
$2.6M 0.58%
29,926
-18,247
-38% -$1.4M
EGAN icon
47
eGain
EGAN
$192M
$2.57M 0.57%
230,988
+108,022
+88% +$983K
INSG icon
48
Inseego
INSG
$120M
$2.54M 0.56%
21,936
+6,325
+41% +$669K
ATEX icon
49
Anterix
ATEX
$1.87B
$2.47M 0.55%
+54,558
New +$2.79M
ONEW icon
50
OneWater Marine
ONEW
$212M
$2.47M 0.55%
+101,733
New +$1.44M
1
2
3 4 5

Similar funds

NEPWA
New England Private Wealth Advisors Wellesley, Massachusetts $866M AUM 15.25% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
RB
Rodgers Brothers Harmony, Pennsylvania $866M AUM 30.05% 1-Year Est. Return
ICCFIA
IDG China Capital Fund III Associates Central Hong Kong, China $868M AUM 24.3% 1-Year Est. Return
PLFA
Pacific Life Fund Advisors Newport Beach, California $871M AUM 16.29% 1-Year Est. Return

EAM Investors's Q2 2020 Portfolio in Review

As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.

  • EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
  • EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
  • EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
  • EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
  • EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
  • EAM Investors opened 147 new positions and closed 97 in Q2 2020.
  • EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.